Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for PRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 10.98M
March 31, 2026 -344.28M
December 31, 2025 -328.39M
September 30, 2025 50.41M
June 30, 2025 17.89M
March 31, 2025 -51.06M
December 31, 2024 -10.92M
September 30, 2024 49.57M
June 30, 2024 -195.92M
March 31, 2024 -91.22M
December 31, 2023 -0.05M
September 30, 2023 0.00
June 30, 2023 5.00M
March 31, 2023 34.00M
Date Value
December 31, 2022 22.59M
September 30, 2022 47.96M
June 30, 2022 34.89M
March 31, 2022 -8.55M
December 31, 2021 10.17M
September 30, 2021 13.55M
June 30, 2021 -24.23M
March 31, 2021 -140.01M
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Heron Therapeutics, Inc. -3.265M
Insmed, Inc. 24.51M
Ionis Pharmaceuticals, Inc. 23.50M
Perspective Therapeutics, Inc. 15.02M
Regeneron Pharmaceuticals, Inc. -92.70M